PDCD1 and neoplasm: Based on these results, we suggested that CM patients with high pyroptosis scores, treated with anti-PD-1/L1, relieved the PD-1/L1 inhibitory effect on T cells populations, allowing them to resume their cytotoxicity and infiltrate the TME, mediating tumor cells pyroptosis or generating an inflammatory response.